Parkinson’s disease symptoms “improved” by oestrogen
New research into sex-based differences of Parkinson’s disease could lead to new treatments.
According to new research, brain-selective oestrogen treatment improves the symptoms of Parkinson’s disease in male mice. This may help explain the sex differences in Parkinson’s disease and could lead to oestrogen-based treatments.
Oestrogen is thought to protect movement neurons from Parkinson’s disease, but how is unknown. Since the patients more susceptible to Parkinson’s disease have low oestrogen levels, oestrogen treatment might be an effective way to delay and reduce symptoms.
Silke Nuber and colleagues at Harvard Medical School treated mouse models of Parkinson’s disease with brain-selective oestrogen and compared the motor performance of males and females before and after treatment.
The female mice showed less severe symptoms at a later age, but oestrogen still improved their symptoms. In male mice, the oestrogen treatment reduced α-synuclein breakdown and buildup and helped with severe symptoms, suggesting that oestrogen could be a viable treatment option for Parkinson’s patients with low oestrogen levels.
The research, Female Sex and Brain-Selective Estrogen Benefit α-Synuclein Tetramerization and the PD-Like Motor Syndrome in 3K Transgenic Mice, was published in JNeurosci.